More than half (55.9 percent) of specimens tested in public health laboratories were influenza B, while the remaining 44.1 percent were influenza A during the week of March 26. In tests performed by clinical laboratories during that time period, 60.9 percent were influenza B.
Despite influenza B’s late-season surge, flu activity is on the decline. For instance, the proportion of deaths attributed to pneumonia and influenza was below the epidemic threshold, and the rate of hospitalizations fell to 1.9 percent, down from 2.7 percent the week prior.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The percent of outpatient visits for flu-like illness also fell to 2.9 percent (from 3.2 percent the week prior), but remained above the national baseline of 2.2 percent.
Nine states (Alabama, Georgia, Kentucky, New York, North Carolina, Rhode Island, South Carolina, Tennessee and Virginia) still have high influenza-like illness activity, while 37 states experienced minimal such activity.
More articles on influenza:
United Kingdom researchers create 1-hour flu test
Study: Flu vaccination significantly decreases risk of pediatric flu death
Flu season not over yet: Positive flu tests see uptick
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
